That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

GSK has agreed to pay $58 per RAPT share, with an upfront payment of $1.9 billion, that will give it global rights to ...

GSK plc agreed to buy Rapt Therapeutics, a US-based biotech developing treatments for patients with inflammatory and ...

GSK is buying Rapt Therapeutics for $2.2 billion, the companies said Tuesday. Rapt stock rocketed.

Hives are itchy red or white bumps that often stem from an allergic reaction. Some rashes are contagious, but hives are not spread from person to person. Corticosteroids and biologics can treat both ...

Investing.com - Piper Sandler initiated coverage on Rapt Therapeutics (NASDAQ:RAPT) with an Overweight rating and a $95.00 price target on Friday, representing over 200% upside from the current price ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

It’s hard to think of vaccination without associating it with a sharp jab in the arm. But there are other, more gentle ways of activating the immune system, such as administering vaccines via the nose ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...